VERTEX PHARMACEUTICALS INC / MA Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Vertex Pharmaceuticals Inc / Ma Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $616M, a 34% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $616M +$156M +34% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $460M +$312M +212% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $147M +$60.6M +70% Dec 31, 2021 10-K 2024-02-15
Q4 2020 $86.6M +$52.7M +155% Dec 31, 2020 10-K 2024-02-15
Q4 2019 $33.9M +$14.4M +73.8% Dec 31, 2019 10-K 2023-02-10
Q3 2019 $29.4M +$22.6M +332% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $27.5M +$21.6M +366% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $25.2M +$20.4M +425% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $19.5M +$15.7M +411% Dec 31, 2018 10-K 2022-02-09
Q3 2018 $6.8M +$6.8M Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $5.9M +$5.9M Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $4.8M +$4.8M Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $3.81M +$3.81M Dec 31, 2017 10-K 2021-02-11
Q3 2017 $0 $0 Sep 30, 2017 10-Q 2017-10-30
Q2 2017 $0 -$400K -100% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $0 -$400K -100% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $0 -$425K -100% Dec 31, 2016 10-K 2020-02-13
Q3 2016 $0 -$900K -100% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 $400K -$500K -55.6% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $400K -$500K -55.6% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $425K -$455K -51.7% Dec 31, 2015 10-K 2019-02-13
Q3 2015 $900K -$4.8M -84.2% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $900K -$2.1M -70% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $900K -$1.7M -65.4% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $880K -$1.14M -56.5% Dec 31, 2014 10-K 2017-02-23
Q3 2014 $5.7M Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $3M Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $2.6M Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $2.02M -$2.08M -50.7% Dec 31, 2013 10-K 2016-02-16
Q4 2012 $4.11M -$254K -5.83% Dec 31, 2012 10-K 2015-02-13
Q4 2011 $4.36M +$1.99M +83.7% Dec 31, 2011 10-K 2014-02-11
Q4 2010 $2.37M Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.